Primagen Holding BV has announced that the U.S. Patent and Trademark Office has granted a patent for its Mitox™ mitochondrial DNA quantification technology as biomarkers for efficacy and adverse ...

Primagen Holding BV will exhibit its products in booth #4463 at the American Society of Clinical Oncology (ASCO) meeting being held in Atlanta, Georgia, from June 2-6, after introducing its Cancer ...

AMSTERDAM, The Netherlands, April 25 /PRNewswire/ -- Primagen Holding BV, a molecular diagnostics company, announced today that the exclusive, worldwide license for the CD133 diagnostic biomarker ...